News About: Pharm. Industry
Pharmaceutical shares boosted by new health minister’s appointment
Shares of pharmaceutical firms were boosted on August 9 by expectations that Chin Soo-hee, nominee for health and welfare minister in the recent cabinet reshuffling, will be more market-oriented than her predecessor, ...
Korean drugmakers at crossroad over unified distribution
Members of the Korea Pharmaceutical Manufacturers Association have a headache over the current unified distribution system.
Wholesalers said the system should be delayed for the next three years until the sound dis...
Wholesalers angered over poor management of drug inventory
Domestic pharmaceutical wholesalers are facing penalty provisions from some pharmaceutical firms due to increased returned goods from pharmacies.
Officials at Ilsung Pharm say it will seek a penalty against pharmac...
Cho-A develops genetically modified pigs with human growth hormone
Cho-A Pharm says it has successfully cloned two pigs that have been genetically modified to produce human growth hormone, aside from its current research to produce EPO drugs from genetically modified pigs.
As its ...
Blue chips over ubiquitous healthcare business
Inspired by a better outlook for the local ubiquitous healthcare, many manufacturers involved in the medical devices and technologies sector are emerging as “blue chips” for domestic and foreign investors.
These en...
Crestor approved for reduction of cardiovascular risk
The Korea Food and Drug Administration has recently approved Crestor (rosuvastatin calcium)) tablets of AstraZeneca to reduce the risk of stroke, myocardial infarction, and arterial revascularization procedures in ind...
Green Cross ranks first in per capita productivity
The labor productivity of major domestic drug manufacturers created by per worker increased sharply in the first quarter of this year, according to data released by market analysts.
Green Cross Corp. topped the lis...
More R&D investment and globalization is daunting challenge for Korea
The Korean government’s new drug pricing policy and crackdown on rebates is ultimately designed to encourage domestic drug manufacturers to invest in R&D for the development of new drugs.
According to government da...
Wave of multifunctional cosmetics hit shelves
The wave of functional cosmetics, which function anti-wrinkle, whitening and ultraviolet protection, is expected to continue, as marketers are realizing that today's consumers want more than the raw product.
Accor...
AstraZeneca PLC appoints new CEO in Indonesia
AstraZeneca announced that Lee Won Bae, incumbent executive managing director of AstraZeneca Korea, is to work for AstraZeneca Indonesia, with effect from August 15 2010.
He joined AstraZeneca Korea in 2005 after s...
